Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM

4.59 Up 0.10(2.23%) May 21, 3:59PM EDT|After Hours : 4.57 Down 0.02 (0.44%) May 21, 4:29PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 29, 2012Apr 29, 2011Apr 29, 2010
Total Revenue 415   322   47  
Cost of Revenue51  219  39  
Gross Profit 364   103   8  
Operating Expenses
Research Development2,463  2,682  2,975  
Selling General and Administrative6,092  7,682  7,235  
Non Recurring30  302   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (8,220) (10,563) (10,201)
Income from Continuing Operations
Total Other Income/Expenses Net(80)286  (151)
Earnings Before Interest And Taxes(8,300)(10,277)(10,352)
Interest Expense7,412  172  155  
Income Before Tax(15,712)(10,448)(10,507)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(15,712)(10,448)(10,507)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (15,712) (10,448) (10,507)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (15,712) (10,448) (10,507)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.